Padia; Janak Khimchand

Patent Applications and Registrations

Patent applications and USPTO patent grants for Padia; Janak Khimchand.The latest application filed is for "derivatives of substituted morpholines and uses thereof".

Company Profile

2.8.6

Padia; Janak Khimchand - Germantown MD
Padia; Janak Khimchand - Ypsilanti MI
Padia; Janak Khimchand - Tucson AZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Derivatives Of Substituted Morpholines And Uses Thereof App 20220306618 - Padia; Janak Khimchand	2022-09-29
Derivatives Of Substituted Morpholines And Uses Thereof App 20220298150 - Padia; Janak Khimchand	2022-09-22
Methods and compositions for inhibition of bromodomain-containing proteins Grant 10,717,739 - Vankayalapati , et al.	2020-07-21
Methods and Compositions for Inhibition of Bromodomain-Containing Proteins App 20190345162 - Vankayalapati; Hariprasad ; et al.	2019-11-14
Methods and compositions for inhibition of bromodomain-containing proteins Grant 10,266,536 - Vankayalapati , et al.	2019-04-23
Methods and Compositions for Inhibition of Bromodomain and Extratermial Proteins App 20190092761 - Yoshioka; Makoto ; et al.	2019-03-28
Methods and Compositions for Inhibition of Bromodomain-Containing Proteins App 20180134715 - Vankayalapati; Hariprasad ; et al.	2018-05-17
Methods and compositions for inhibition of bromodomain-containing proteins Grant 9,695,179 - Vankayalapati , et al. July 4, 2	2017-07-04
Methods And Compositions For Inhibition Of Bromodomain-containing Proteins App 20160024096 - Vankayalapati; Hariprasad ; et al.	2016-01-28
Heterocycles as cholecystokinin (CCK) ligands Grant 6,897,213 - Padia May 24, 2	2005-05-24
Method for treating and preventing inflammation and atherosclerosis Grant 5,972,980 - Cornicelli , et al. October 26, 1	1999-10-26
Benzimidazole compounds useful for the treatment of inflammatory disease, atherosclerosis, restenosis or inhibiting lipoxygenase Grant 5,958,950 - Padia , et al. September 28, 1	1999-09-28
Quinazolinone derivatives as cholecystokinin (CCK) ligands Grant 5,869,665 - Padia February 9, 1	1999-02-09
Quinazolinone derivatives as cholyecystokinin (CCK) ligands Grant 5,756,502 - Padia May 26, 1	1998-05-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.